babies

Hologics Preterm Birth Drug Makena Receives FDA Approval

Makena, previously called Gestiva, has faced years of delays at the FDA, which issued an "approvable" letter for the drug in October 2006, but delayed further action in January 2009. The agency requested more information on the dr

hologic, holx, drug, makena, premature birth, fda, gestiva, approval, medicine, health care, trial, clinical benefit, babies, infants, kv pharma, deal, cash, payment, financial, assets

Hologic (HOLX) is down fractionally in choppy trade around the even mark, after announcing today that its drug, Makena, designed to prevent premature birth, was approved by the U.S. Food and Drug Administration, but it added that

By Stephanie Shyu
sshyu@fnno.com

Latest News from FNNO

Possible Bearish Inside Day Candle Patte...

Analyzing the price chart for Staples (NASDAQ:SPLS) has revealed a potential bearish i ...

Possible Bearish Inside Day Candle Patte...

Analysts have spotted a possible bearish inside day candle pattern in Mead Johnson Nutr ...

Possible Bearish Inside Day Candle Patte...

Analyzing the price chart for US Bancorp (NYSE:USB) has revealed a potential bearish i ...

Bottom 5 Companies in the Systems Softwa...

Analysis was conducted on the Systems Software industry to measure relative performance ...

Analysis of Relative Performance in the ...

Here are 5 stocks in the Steel industry ranked by performance. We compiled the trading ...

Short-term Underperformance Detected in ...

Below are five companies in the Specialty Stores industry that underperformed yesterday ...

Analysis of Relative Performance in the ...

Here are 5 stocks in the Specialty Chemicals industry ranked by performance. We compil ...

Short-term Underperformance Detected in ...

Below are five companies in the Specialized REITs industry that underperformed yesterda ...

Most Popular Video News